Xenon Pharmaceuticals Inc.Xenon Pharmaceuticals Inc.Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc.

No trades
See on Supercharts

XENE fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Xenon Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It develops therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system (CNS) conditions. The company's products include XEN496, XEN1101, XEN901 and XEN007. Xenon Pharmaceuticals was founded by Simon Neil Pimstone, Johannes J. P. Kastelein and Michael R. Hayden on November 5, 1996 and is headquartered in Burnaby, Canada.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
XENE has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company